Hemizygous deletion of Tbk1 worsens neuromuscular junction pathology in TDP-43


Journal

Experimental neurology
ISSN: 1090-2430
Titre abrégé: Exp Neurol
Pays: United States
ID NLM: 0370712

Informations de publication

Date de publication:
01 2021
Historique:
received: 15 04 2020
revised: 26 09 2020
accepted: 04 10 2020
pubmed: 11 10 2020
medline: 20 4 2021
entrez: 10 10 2020
Statut: ppublish

Résumé

Mutations in the genes TARDBP (encoding the TDP-43 protein) and TBK1 can cause familial ALS. Neuronal cytoplasmatic accumulations of the misfolded, hyperphosphorylated RNA-binding protein TDP-43 are the pathological hallmark of most ALS cases and have been suggested to be a key aspect of ALS pathogenesis. Pharmacological induction of autophagy has been shown to reduce mutant TDP-43 aggregates and alleviate motor deficits in mice. TBK1 is exemplary for several other ALS genes that regulate autophagy. Consequently, we employed double mutant mice with both a heterozygous Tbk1 deletion and transgenic expression of human TDP-43

Identifiants

pubmed: 33038415
pii: S0014-4886(20)30327-7
doi: 10.1016/j.expneurol.2020.113496
pii:
doi:

Substances chimiques

DNA-Binding Proteins 0
TARDBP protein, human 0
Tbk1 protein, mouse EC 2.7.1.-
Protein Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

113496

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Kirsten Sieverding (K)

Department of Neurology, University of Ulm, Ulm, Germany.

Johannes Ulmer (J)

Department of Neurology, University of Ulm, Ulm, Germany.

Clara Bruno (C)

Department of Neurology, University of Ulm, Ulm, Germany.

Takashi Satoh (T)

Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.

William Tsao (W)

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States; Cellular and Molecular Medicine Program, Johns Hopkins University School of Medicine, Baltimore, United States.

Axel Freischmidt (A)

Department of Neurology, University of Ulm, Ulm, Germany.

Shizuo Akira (S)

Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.

Philip C Wong (PC)

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States; Cellular and Molecular Medicine Program, Johns Hopkins University School of Medicine, Baltimore, United States.

Albert C Ludolph (AC)

Department of Neurology, University of Ulm, Ulm, Germany.

Karin M Danzer (KM)

Department of Neurology, University of Ulm, Ulm, Germany.

Christian S Lobsiger (CS)

Institut du Cerveau et de la Moelle Épinière, Institut National de la Santé et de la Recherche Médicale Unité 1127, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7225, Sorbonne Université, Paris, France.

David Brenner (D)

Department of Neurology, University of Ulm, Ulm, Germany; Division of Neurodegenerative Disorders, Department of Neurology, Mannheim Center for Translational Neuroscience, Medical Faculty Mannheim, Heidelberg University, Germany.

Jochen H Weishaupt (JH)

Department of Neurology, University of Ulm, Ulm, Germany; Division of Neurodegenerative Disorders, Department of Neurology, Mannheim Center for Translational Neuroscience, Medical Faculty Mannheim, Heidelberg University, Germany. Electronic address: jochen.weishaupt@medma.uni-heidelberg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH